Heat Therapy Versus Exercise Training in Hypertension
Part of paid clinical trials in Eugene, Oregon.
- Sponsor
- University of Oregon
- Study ID
- NCT03557502
- Status
- Completed
Conditions
- Arterial Hypertension
- Cardiovascular Diseases
- Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Heat Therapy Group — OTHER30 sessions of immersion in 40.5 degree celsius water for 45 minutes per session
- Aerobic Exercise Group — OTHER30 sessions of aerobic exercise training for 45 minutes at 60% of VO2peak
Study Details
This is a clinical trial to determine whether 30 sessions of heat therapy in the form of hot water immersion is better than 30 sessions of traditional aerobic exercise training on blood pressure reduction in people with elevated or Stage 1 hypertension.
Key Dates
- Start date
- Dec 1, 2019
- Status verified
- Sep 2022
- Primary completion
- Dec 30, 2023
- Completion
- Dec 30, 2023
Study Design
- Enrollment
- 44 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Heat Therapy GroupGroup will undergo 30 sessions of heat therapy over approximately 10 weeks. Sessions will require subjects to be immersed in hot water for up to 45 minutes per session.
- Experimental: Aerobic Exercise GroupGroup will undergo 30 sessions of aerobic exercise training over approximately 10 weeks. Sessions will require subjects to exercise on a cycle ergometer for up to 45 minutes per session.
Primary Outcome Measure
Blood Pressure Reduction: Change in Systolic and Diastolic Ambulatory Blood Pressure (mmHg) After 30 Sessions of Intervention [ Time Frame: 10 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Oregon | Eugene | Oregon | 97403 | - |
Find similar trials in Eugene, OR
By condition
By specialty
By research site
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona